Literature DB >> 31155484

Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity.

Soham Chanda1, Cheen Euong Ang2, Qian Yi Lee2, Michael Ghebrial3, Daniel Haag3, Yohei Shibuya3, Marius Wernig3, Thomas C Südhof4.   

Abstract

Human pluripotent stem cells can be rapidly converted into functional neurons by ectopic expression of proneural transcription factors. Here we show that directly reprogrammed neurons, despite their rapid maturation kinetics, can model teratogenic mechanisms that specifically affect early neurodevelopment. We delineated distinct phases of in vitro maturation during reprogramming of human neurons and assessed the cellular phenotypes of valproic acid (VPA), a teratogenic drug. VPA exposure caused chronic impairment of dendritic morphology and functional properties of developing neurons, but not those of mature neurons. These pathogenic effects were associated with VPA-mediated inhibition of the histone deacetylase (HDAC) and glycogen synthase kinase-3 (GSK-3) pathways, which caused transcriptional downregulation of many genes, including MARCKSL1, an actin-stabilizing protein essential for dendritic morphogenesis and synapse maturation during early neurodevelopment. Our findings identify a developmentally restricted pathogenic mechanism of VPA and establish the use of reprogrammed neurons as an effective platform for modeling teratogenic pathways.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MARCKSL1; anti-epileptic drug; autism; cellular reprogramming; gene expression; human neurons; neurodevelopment; spina bifida; valproic acid

Year:  2019        PMID: 31155484      PMCID: PMC6609489          DOI: 10.1016/j.stem.2019.04.021

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  55 in total

1.  Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis.

Authors:  D L Vaden; D Ding; B Peterson; M L Greenberg
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

2.  MacMARCKS, a novel member of the MARCKS family of protein kinase C substrates.

Authors:  J Li; A Aderem
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

Review 3.  Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.

Authors:  H K Manji; R McNamara; G Chen; R H Lenox
Journal:  Aust N Z J Psychiatry       Date:  1999-12       Impact factor: 5.744

4.  The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth.

Authors:  P X Yuan; L D Huang; Y M Jiang; J S Gutkind; H K Manji; G Chen
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

5.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Authors:  M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

6.  Fetal valproate syndrome and autism: additional evidence of an association.

Authors:  G Williams; J King; M Cunningham; M Stephan; B Kerr; J H Hersh
Journal:  Dev Med Child Neurol       Date:  2001-03       Impact factor: 5.449

7.  A clinical study of 57 children with fetal anticonvulsant syndromes.

Authors:  S J Moore; P Turnpenny; A Quinn; S Glover; D J Lloyd; T Montgomery; J C Dean
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

8.  A common mechanism of action for three mood-stabilizing drugs.

Authors:  Robin S B Williams; Lili Cheng; Anne W Mudge; Adrian J Harwood
Journal:  Nature       Date:  2002-05-16       Impact factor: 49.962

9.  Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.

Authors:  T O'Donnell; S Rotzinger; T T Nakashima; C C Hanstock; M Ulrich; P H Silverstone
Journal:  Brain Res       Date:  2000-10-13       Impact factor: 3.252

10.  Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.

Authors:  Anita C Hall; Angela Brennan; Robert G Goold; Karen Cleverley; Fiona R Lucas; Phillip R Gordon-Weeks; Patricia C Salinas
Journal:  Mol Cell Neurosci       Date:  2002-06       Impact factor: 4.314

View more
  13 in total

1.  An Autism-Associated Mutation Impairs Neuroligin-4 Glycosylation and Enhances Excitatory Synaptic Transmission in Human Neurons.

Authors:  Thomas P Cast; Daniel J Boesch; Kim Smyth; Alisa E Shaw; Michael Ghebrial; Soham Chanda
Journal:  J Neurosci       Date:  2020-12-02       Impact factor: 6.167

Review 2.  Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.

Authors:  Mahdi Rizk; Zahraa Saker; Hisham F Bahmad; Sanaa Nabha; Hayat Harati; Youssef Fares
Journal:  Mol Biol Rep       Date:  2021-03-01       Impact factor: 2.316

3.  RTN4/NoGo-receptor binding to BAI adhesion-GPCRs regulates neuronal development.

Authors:  Jie Wang; Yi Miao; Rebecca Wicklein; Zijun Sun; Jinzhao Wang; Kevin M Jude; Ricardo A Fernandes; Sean A Merrill; Marius Wernig; K Christopher Garcia; Thomas C Südhof
Journal:  Cell       Date:  2021-11-09       Impact factor: 41.582

4.  Induction of synapse formation by de novo neurotransmitter synthesis.

Authors:  Scott R Burlingham; Nicole F Wong; Lindsay Peterkin; Lily Lubow; Carolina Dos Santos Passos; Orion Benner; Michael Ghebrial; Thomas P Cast; Matthew A Xu-Friedman; Thomas C Südhof; Soham Chanda
Journal:  Nat Commun       Date:  2022-06-01       Impact factor: 17.694

5.  CASK loss of function differentially regulates neuronal maturation and synaptic function in human induced cortical excitatory neurons.

Authors:  Danny McSweeney; Rafael Gabriel; Kang Jin; Zhiping P Pang; Bruce Aronow; ChangHui Pak
Journal:  iScience       Date:  2022-09-23

6.  Kinetic modeling of stem cell transcriptome dynamics to identify regulatory modules of normal and disturbed neuroectodermal differentiation.

Authors:  Johannes Meisig; Nadine Dreser; Marion Kapitza; Margit Henry; Tamara Rotshteyn; Jörg Rahnenführer; Jan G Hengstler; Agapios Sachinidis; Tanja Waldmann; Marcel Leist; Nils Blüthgen
Journal:  Nucleic Acids Res       Date:  2020-12-16       Impact factor: 16.971

Review 7.  Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.

Authors:  Kenly Wuputra; Chia-Chen Ku; Deng-Chyang Wu; Ying-Chu Lin; Shigeo Saito; Kazunari K Yokoyama
Journal:  J Exp Clin Cancer Res       Date:  2020-06-03

Review 8.  S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy.

Authors:  Asher Ornoy; Maria Becker; Liza Weinstein-Fudim; Zivanit Ergaz
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

Review 9.  Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.

Authors:  Kenichi Horisawa; Atsushi Suzuki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2020       Impact factor: 3.493

Review 10.  Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.

Authors:  Juan Antonio Garcia-Leon; Laura Caceres-Palomo; Elisabeth Sanchez-Mejias; Marina Mejias-Ortega; Cristina Nuñez-Diaz; Juan Jose Fernandez-Valenzuela; Raquel Sanchez-Varo; Jose Carlos Davila; Javier Vitorica; Antonia Gutierrez
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.